Business Description
Catalent Inc
NAICS : 325412
SIC : 2834
ISIN : US1488061029
Compare
Compare
Traded in other countries / regions
CTLT.USA0C8.GermanyCTLT.Mexico IPO Date
2019-07-30Description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.4 | |||||
| Debt-to-EBITDA | 12.4 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.6 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EPS without NRI Growth Rate | -59 | |||||
| 3-Year FCF Growth Rate | 39.7 | |||||
| 3-Year Book Growth Rate | -4.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 114.01 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.76 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 100 | |||||
| 14-Day RSI | 100 | |||||
| 6-1 Month Momentum % | 23.91 | |||||
| 12-1 Month Momentum % | 23.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 1.93 | |||||
| Cash Ratio | 0.34 | |||||
| Days Inventory | 75.6 | |||||
| Days Sales Outstanding | 69.81 | |||||
| Days Payable | 39.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | -0.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.82 | |||||
| Operating Margin % | -2.47 | |||||
| Net Margin % | -9.34 | |||||
| FCF Margin % | 2.37 | |||||
| ROE % | -11.29 | |||||
| ROA % | -4.18 | |||||
| ROIC % | -1.43 | |||||
| ROC (Joel Greenblatt) % | -2.02 | |||||
| ROCE % | -1.04 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 46.01 | |||||
| Shiller PE Ratio | 90.85 | |||||
| PS Ratio | 2.61 | |||||
| PB Ratio | 3.25 | |||||
| Price-to-Tangible-Book | 31.58 | |||||
| Price-to-Free-Cash-Flow | 115.84 | |||||
| Price-to-Operating-Cash-Flow | 28.88 | |||||
| EV-to-EBIT | -177.3 | |||||
| EV-to-Forward-EBIT | 43.1 | |||||
| EV-to-EBITDA | 40.44 | |||||
| EV-to-Forward-EBITDA | 19.82 | |||||
| EV-to-Revenue | 3.65 | |||||
| EV-to-Forward-Revenue | 3.34 | |||||
| EV-to-FCF | 162.97 | |||||
| Price-to-Projected-FCF | 7.81 | |||||
| Price-to-Median-PS-Value | 1.1 | |||||
| Earnings Yield (Greenblatt) % | -0.56 | |||||
| FCF Yield % | 0.86 | |||||
| Forward Rate of Return (Yacktman) % | 4.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Catalent Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 79,333.743 | ||
| EPS (TTM) (MXN) | -40.367 | ||
| Beta | -0.64 | ||
| Volatility % | 23.91 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR (MXN) | 0.00632 | ||
| 20-Day SMA (MXN) | 1020 | ||
| 12-1 Month Momentum % | 23.91 | ||
| 52-Week Range (MXN) | 823.19 - 1020 | ||
| Shares Outstanding (Mil) | 181.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Catalent Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Catalent Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Catalent Inc Frequently Asked Questions
What is Catalent Inc(MEX:CTLT)'s stock price today?
The current price of MEX:CTLT is MXN1020.00. The 52 week high of MEX:CTLT is MXN1020.00 and 52 week low is MXN823.19.
When is next earnings date of Catalent Inc(MEX:CTLT)?
The next earnings date of Catalent Inc(MEX:CTLT) is 2025-02-07 Est..
Does Catalent Inc(MEX:CTLT) pay dividends? If so, how much?
Catalent Inc(MEX:CTLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers